The evaluation of human epidermal growth factor receptor 2 (HER2) expression is essential to formulate a precise treatment for breast cancer. The routine evaluation of HER2 is conducted with immunohistochemical techniques (IHC), which is very expensive. Therefore, we propose a breast cancer immunohistochemical (BCI) benchmark attempting to synthesize IHC data directly with the paired hematoxylin and eosin (HE) stained images. The dataset contains 4870 registered image pairs, covering a variety of HER2 expression levels (0, 1+, 2+, 3+).
12 PAPERS • 1 BENCHMARK
The REFLACX dataset contains eye-tracking data for 3,032 readings of chest x-rays by five radiologists. The dictated reports were transcribed and have timestamps synchronized with the eye-tracking data.
6 PAPERS • NO BENCHMARKS YET
The LIMUC dataset is the largest publicly available labeled ulcerative colitis dataset that compromises 11276 images from 564 patients and 1043 colonoscopy procedures. Three experienced gastroenterologists were involved in the annotation process, and all images are labeled according to the Mayo endoscopic score (MES).
4 PAPERS • 1 BENCHMARK
Several datasets are fostering innovation in higher-level functions for everyone, everywhere. By providing this repository, we hope to encourage the research community to focus on hard problems. In this repository, we present the real results severity (BIRADS) and pathology (post-report) classifications provided by the Radiologist Director from the Radiology Department of Hospital Fernando Fonseca while diagnosing several patients (see dataset-uta4-dicom) from our User Tests and Analysis 4 (UTA4) study. Here, we provide a dataset for the measurements of both severity (BIRADS) and pathology classifications concerning the patient diagnostic. Work and results are published on a top Human-Computer Interaction (HCI) conference named AVI 2020 (page). Results were analyzed and interpreted from our Statistical Analysis charts. The user tests were made in clinical institutions, where clinicians diagnose several patients for a Single-Modality vs Multi-Modality comparison. For example, in these t
1 PAPER • NO BENCHMARKS YET
Several datasets are fostering innovation in higher-level functions for everyone, everywhere. By providing this repository, we hope to encourage the research community to focus on hard problems. In this repository, we present our severity rates (BIRADS) of clinicians while diagnosing several patients from our User Tests and Analysis 4 (UTA4) study. Here, we provide a dataset for the measurements of severity rates (BIRADS) concerning the patient diagnostic. Work and results are published on a top Human-Computer Interaction (HCI) conference named AVI 2020 (page). Results were analyzed and interpreted from our Statistical Analysis charts. The user tests were made in clinical institutions, where clinicians diagnose several patients for a Single-Modality vs Multi-Modality comparison. For example, in these tests, we used both prototype-single-modality and prototype-multi-modality repositories for the comparison. On the same hand, the hereby dataset represents the pieces of information of bot
EBHI-Seg is a dataset containing 5,170 images of six types of tumor differentiation stages and the corresponding ground truth images. The dataset can provide researchers with new segmentation algorithms for medical diagnosis of colorectal cancer.
FractureAtlas is a musculoskeletal bone fracture dataset with annotations for deep learning tasks like classification, localization, and segmentation. The dataset contains a total of 4,083 X-Ray images with annotation in COCO, VGG, YOLO, and Pascal VOC format. This dataset is made freely available for any purpose. The data provided within this work are free to copy, share or redistribute in any medium or format. The data might be adapted, remixed, transformed, and built upon. The dataset is licensed under a CC-BY 4.0 license. It should be noted that to use the dataset correctly, one needs to have knowledge of medical and radiology fields to understand the results and make conclusions based on the dataset. It's also important to consider the possibility of labeling errors.
Onchocerciasis is causing blindness in over half a million people in the world today. Drug development for the disease is crippled as there is no way of measuring effectiveness of the drug without an invasive procedure. Drug efficacy measurement through assessment of viability of onchocerca worms requires the patients to undergo nodulectomy which is invasive, expensive, time-consuming, skill-dependent, infrastructure dependent and lengthy process.